Myeloid Cells is a quarterly, gold open-access journal published by Science Exploration Press, serving as a dedicated platform for the study of myeloid biology across health and disease. Myeloid cells—including monocytes, macrophages, dendritic cells, and granulocytes—play essential roles in immunity, tissue homeostasis, and pathology. With advances in single-cell technologies, imaging, and multi-omics, the complexity and therapeutic relevance of myeloid populations are being uncovered at unprecedented depth. Myeloid Cells provides a forum for integrating discoveries from fundamental biology with translational and clinical research, aiming to accelerate progress toward innovative diagnostics and therapies.

Aims and Scope

Myeloid Cells is committed to advancing knowledge of the biology, diversity, and medical relevance of myeloid cells. By publishing rigorous basic, translational, and clinical studies, the journal fosters cross-disciplinary dialogue and innovation. The journal aims to bridge mechanistic insights with therapeutic applications, supporting the development of strategies that harness myeloid cells for health and disease intervention.

We welcome manuscripts covering theoretical, experimental, preclinical, translational, and clinical aspects of myeloid cell research. Key research areas include, but are not limited to:

• Ontogeny, differentiation, and lineage plasticity of myeloid cells
• Myeloid cell heterogeneity and transcriptional regulation
• Roles in immunity, inflammation, tissue repair, and homeostasis
• Myeloid-driven pathologies in infection, autoimmunity, cancer, and metabolic disease
• Systems biology, single-cell, and multi-omics approaches to myeloid biology
• Myeloid cell interactions with tissue and stromal environments
• Biomarker discovery and diagnostic applications
• Myeloid-targeted therapeutics, including immunotherapies and regenerative medicine
• Preclinical and clinical trial studies involving myeloid-directed interventions
• Ethical, societal, and regulatory considerations in translational myeloid research

Myeloid Cells publishes original research articles, reviews, short communications, perspectives, editorials, and commentaries to serve a diverse scientific and clinical community.

Publication Frequency

Quarterly.

Publishing Model

Myeloid Cells is an open-access journal that ensures all content is freely available to users and their institutions without any associated costs. Users are granted full rights to read, download, copy, distribute, print, search, and link to the full texts of articles, as well as to use them for any other lawful purposes, without the need for prior permission from the publisher or the author. This policy aligns with the principles of open access, promoting the broad dissemination of scientific knowledge.

Licensing and Copyright

Myeloid Cells is published under the Creative Commons Attribution 4.0 International License. Authors retain the copyright of their work and agree to make their original works freely available for use, copying, and redistribution in all formats without needing permission, provided that proper citation is given to the authors and the original source.

Digital Archive

Portico